These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17763431

  • 21. Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy.
    Yu Z, Cheng H, Liang Y, Ding T, Yan C, Gao C, Wen H.
    Front Immunol; 2021; 12():642070. PubMed ID: 33936057
    [Abstract] [Full Text] [Related]

  • 22. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts.
    Shi MH, Tsui FW, Rubin LA.
    J Rheumatol; 1991 Feb; 18(2):252-8. PubMed ID: 2023220
    [Abstract] [Full Text] [Related]

  • 23. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.
    Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
    [Abstract] [Full Text] [Related]

  • 24. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M.
    Arthritis Rheum; 2006 Oct 15; 55(5):791-8. PubMed ID: 17013837
    [Abstract] [Full Text] [Related]

  • 25. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
    Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.
    Rheumatology (Oxford); 2015 Jul 15; 54(7):1194-9. PubMed ID: 25524922
    [Abstract] [Full Text] [Related]

  • 26. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
    Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG, Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Arthritis Rheum; 2004 May 15; 50(5):1595-603. PubMed ID: 15146430
    [Abstract] [Full Text] [Related]

  • 27. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.
    Hengstman GJ, van Engelen BG, van Venrooij WJ.
    Curr Opin Rheumatol; 2004 Nov 15; 16(6):692-9. PubMed ID: 15577606
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M.
    J Rheumatol; 1984 Oct 15; 11(5):663-5. PubMed ID: 6334746
    [Abstract] [Full Text] [Related]

  • 33. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
    Espada G, Maldonado Cocco JA, Fertig N, Oddis CV.
    J Rheumatol; 2009 Nov 15; 36(11):2547-51. PubMed ID: 19833756
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE, Helmers SB.
    Autoimmunity; 2010 Apr 15; 43(3):239-43. PubMed ID: 20187702
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies].
    Zu N, Wang GC.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1157-60. PubMed ID: 21756766
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.